-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

321. Blood Coagulation and Fibrinolytic Factors: Poster II Clinically Relevant Abstract

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
antibodies, Biological, Bleeding Disorders, Coronaviruses, Hemophilia, SARS-CoV-2/COVID-19, Animal models, Bleeding and Clotting, Diseases, Therapies, Genetic Disorders, Biological Processes, Study Population, Clinically relevant, inflammation, VWD, molecular interactions, pathogenesis
Sunday, December 6, 2020: 7:00 AM-3:30 PM

Kazuki Yamaguchi1*, Tetsuhiro Soeda, PhD2*, Motohiko Sato3*, Norihito Shibahara, PhD3*, Hikaru Koga3*, Mina Ichiki3*, Eri Joyashiki3*, Yuri Teranishi4*, Kei Nishimura3*, Hirotake Shiraiwa2*, Hidetomo Kitamura, PhD, DVM3*, Tomoyuki Igawa, PhD4*, Hiroko Konishi3* and Takehisa Kitazawa, DVM3*

1Chugai Pharmaceutical Co., Ltd., Gotemba City, Shizuoka, Japan
2Chugai Pharmaceutical Co., Ltd., Kamakura, Japan
3Chugai Pharmaceutical Co., Ltd., Gotemba, Japan
4Chugai Pharmabody Research Pte., Ltd., Singapore, Singapore

Rebecca Jane Shaw, MBChB (Hons)1*, James Austin, PhD1*, Joseph Taylor2*, Tina Dutt, PhD2*, Guozheng Wang, MD, PhD1*, Simon Timothy Abrams, PhD, BSc1* and Cheng Hock Toh, MD1*

1Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom
2Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom

Mario von Depka, MD, PhD1*, Katharina Kaiser, DVM1*, Carsten Detering1*, Christiane Pfarrer, DVM, Prof2*, Mahnaz Ekhlasi-Hundrieser, PhD1* and Stefanie Lehner, DVM, PhD1*

1Werlhof-Institute, Hannover, Germany
2Institute for Anatomy, University of Veterinary Medicine Hannover, Hannover, Germany

Shravan Morla1*, Hiroshi Deguchi, MD, PhD1*, Rolf Brekken, PhD2* and John H. Griffin, PhD3

1The Scripps Research Institute, La Jolla, CA
2University of Texas Southwestern Medical Center, Dallas, TX
3Scripps Research Institute, La Jolla, CA

Elisabeth Andersen, MSc, PhD1,2*, Maria Eugenia Chollet, MD, PhD1,2*, Marit Sletten3*, Benedicte Stavik, PhD1,2*, Christiane Filion Myklebust, MSc1,2*, Ellen Skarpen, PhD4*, Paul Hoff Backe5,6*, Per Morten Sandset, MD, PhD1,2,7, Heidi Glosli1*, Carola Henriksson6,7* and Nina Iversen3*

1Department of Hematology, Oslo University Hospital, Oslo, Norway
2Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway
3Department of Medical Genetics, Oslo University Hospital, Oslo, Norway
4Core Facility for Advanced Light Microscopy, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
5Department of Microbiology, Oslo University Hospital, Oslo, Norway
6Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway
7Institute of Clinical Medicine, University of Oslo, Oslo, Norway

Marianne Kjalke, PhD1* and Søren Andersen, PhD2*

1Global Drug Discovery, Novo Nordisk A/S, Måløv, Denmark
2Global Development, Novo Nordisk A/S, Søborg, Denmark

Amanda P. Waller, PhD1*, Michael A. Durda, BS1*, Kennedy Franz1*, Eman Abdelghani, MD1* and Bryce A. Kerlin, MD2,3

1The Research Institute at Nationwide Children's Hospital, Columbus, OH
2Division of Pediatric Hematology/Oncology, Nationwide Children's Hospital, Columbus, OH
3Center for Clinical and Translational Research, The Research Institute at Nationwide Children’s Hospital, Department of Pediatrics, Division of Hematology/Oncology/BMT, The Ohio State University College of Medicine, Nationwide Children’s Hospital, Columbus, OH

Roberto Caputo, MD1*, Maria Teresa Sartori, MD2*, Andrea Leonardi, MD3*, Anna Lotti Suffredini, BSc (Bio)4*, Mirella Calcinai, MD4*, Roberto Crea, DVM, MSc5*, Prasad Mathew, MD6, Charles Nakar, MD7*, Neelam Thukral, CCRC7* and Amy D Shapiro, MD7

1Dept of Ophthalmology, A. Meyer Children's Hospital, Florence, Italy
2Medical Clinic, Internal Medicine, Padua University Hospital, Padua, Italy
3Neuroscience Dpt, Eye Clinic, Padua University, Padua, Italy
4Clinical Research Group, Kedrion SpA, Lucca, Italy
5Global Medical Affairs, Kedrion SpA, Lucca, Italy
6Global Medical Affairs, Kedrion SpA, Albuquerque, NM
7Indiana Hemophilia & Thrombosis Center, Indianapolis, IN

*signifies non-member of ASH